Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income | $0.0 | ($6,566.1K) | ($17.1M) | ($11.4M) | ($17.4M) | ($19.0M) | ($24.9M) | ($31.1M) | ($110.5M) | ($223.7M) | ($587.3M) | ($348.7M) | ($719.7M) | ($425.0M) |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, argenx SE's last 12-month Operating Income is ($385.9M), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, argenx SE's Operating Income growth was (3.6%). The average annual Operating Income growth rates for argenx SE have been N/A over the past three years, 18.0% over the past five years.
Over the last year, argenx SE's Operating Income growth was (3.6%), which is lower than industry growth of (0.1%). It indicates that argenx SE's Operating Income growth is Bad.